[Comparison of the optical coherence method (Zeiss IOL-Master) with two ultrasonographic biometric methods for the calculation of posterior chamber intraocular lenses after phacoemulsification as part of clinical routine].
The aim of this work was to investigate the accuracy of prediction of three different biometric methods for the calculation of posterior chamber intraocular lenses. In 59 consecutive patients who underwent extracapsular cataract-extraction with posterior chamber intraocular lens implantation, we compared the refractive results at the first day (D1) and 6 weeks (W6) after surgery with the calculated refraction of three biometric methods: the Carl Zeiss "IOL-Master 99" (IOLM), the Biovision "Echograph Class 1 - Type B" (BIOV) and the Allergan Humphrey "Ultrasonic Biometer Mod. 820" (AHUB). For statistical calculation box-plots, the Wilcoxon signed-rank test and linear regression analysis were used. In all patients the mean of the postoperative refraction was - 0.07 D (SD: 1.41) at day 1 and 0.12 D (SD: 1.18) at week 6. Compared to the postoperative refraction at week 6, the calculated refractive values were higher in all three measuring devices: IOLM: + 0.28 D (SD: 0.67), BIOV: + 0.60 D (SD: 0.88), AHUB: + 0.26 D (SD: 0.92). There were no statistically significant differences between IOLM and BIOV, or respectively, AHUB and BIOV (p < 0.0001), but a significant difference was found between IOLM and AHUB, (p = 0.906). To adjust for systematic differences of the agreement, one can calculate the postoperative refraction at week 6 (REF6) from IOLM by using the linear regression formula: REF6 = 1.1 x IOLM + 0.3. A comparison between the three biometric methods and the refractive results at day 1 and week 6 after cataract surgery with implantation of a posterior chamber intraocular lens showed that the calculated mean values obtained from the three biometric methods are higher than the real postoperative refraction. Calculations using the Zeiss IOL-Master and the Allergan Humphrey Ultrasonic Biometer are closer to the patient's postoperative refraction than calculations using the Biovision Echograph.